GlassScriptPhysician profile
Christopher N Mcdaniels
NPI 1417918814
$10,353.77
in general payments reported to CMS, 2019-2025
63 companies · $1,782 in 2025
The $1,782 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $363 · 2021: $1,005 · 2022: $1,523 · 2023: $2,361 · 2024: $1,674 · 2025: $1,782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,817.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,524.25 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,488.33 | 2021-2025 | |
| Lilly USA, LLC | $943.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $780.12 | 2019-2025 | |
| Glaxosmithkline, LLC. | $660.52 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $588.03 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $374.16 | 2019-2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $339.29 | 2019-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $283.82 | 2019-2025 | Xifaxan |
| Amgen INC. | $241.29 | 2019-2024 | Repatha, Otezla, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $239.55 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $228.17 | 2022-2024 | Quviviq |
| Supernus Pharmaceuticals, INC. | $189.99 | 2022-2023 | Qelbree |
| Bausch Health US, LLC | $155.92 | 2019-2024 | Aplenzin, Wellbutrin |
| Axsome Therapeutics, INC. | $151.24 | 2024-2025 | Auvelity, Symbravo |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $148.05 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $117.52 | 2019-2025 | |
| Cequr Corporation | $105.80 | 2022-2024 | Cequr Simplicity |
| Abbott Laboratories | $103.66 | 2021-2025 | Eterna, Proclaim |
| Exact Sciences Corporation | $101.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $84.61 | 2022 | |
| Gilead Sciences, INC. | $84.36 | 2019-2020 | |
| Amarin Pharma, INC. | $80.76 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $78.74 | 2023-2025 | Rexulti |
| Allergan, INC. | $78.34 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $71.13 | 2024-2025 | Caplyta |
| Viiv Healthcare Company | $70.00 | 2024-2025 | Apretude |
| Merck Sharp & Dohme LLC | $68.28 | 2023-2025 | Gardasil 9, Vaxneuvance, Verquvo |
| Ironshore Pharmaceuticals INC. | $63.07 | 2019 | |
| Phathom Pharmaceuticals, INC. | $52.45 | 2025 | Voquezna |
| Daiichi Sankyo INC. | $51.54 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $48.10 | 2022-2025 | Contrave |
| Jazz Pharmaceuticals INC. | $44.13 | 2021-2022 | |
| Abiomed | $40.43 | 2024-2025 | Impella |
| Medtronic, INC. | $39.20 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Eisai INC. | $39.18 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $36.30 | 2019-2022 | |
| Adlon Therapeutics L.P. | $34.57 | 2019-2020 | |
| Dynavax Technologies Corporation | $34.12 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $32.47 | 2021 | |
| Edwards Lifesciences Corporation | $31.85 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Neos Therapeutics, LP | $29.04 | 2024 | Adzenys Xr-Odt |
| C2n Diagnostics, LLC | $28.05 | 2025 | Precivityad2 |
| Lundbeck LLC | $25.59 | 2024 | Rexulti |
| Nestle Healthcare Nutrition INC. | $24.04 | 2021 | |
| Masimo Corporation | $23.39 | 2023 | Patient Safetynet System |
| Sandoz INC. | $22.43 | 2025 | Hyrimoz |
| Sumitomo Pharma America, INC. | $20.72 | 2024 | Gemtesa |
| Regeneron Healthcare Solutions, INC. | $20.37 | 2023 | Evkeeza |
| Ars Pharmaceuticals Operations, INC. | $20.02 | 2025 | Neffy |
| Ibsa Pharma INC. | $18.43 | 2021 | |
| Insightec,INC | $18.40 | 2025 | Exablate |
| Horizon Therapeutics Plc | $17.49 | 2021 | |
| Grifols USA, LLC | $17.32 | 2019 | |
| Vivus LLC | $16.88 | 2023 | Qsymia |
| Phadia US INC. | $16.70 | 2025 | Immunocap |
| Dexcom, INC. | $16.66 | 2024 | Dexcom G6 Transmitter |
| Shire North American Group INC | $16.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.02 | 2021 | |
| Seqirus USA INC | $15.53 | 2025 | Flucelvax, Fluad |
| Echosens North America, INC. | $14.91 | 2025 | Fibroscan |
| Teva Pharmaceuticals USA, INC. | $14.12 | 2021 | |
| Genentech USA, INC. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mcdaniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.